PFM Health Sciences, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001442756

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2023 · 60 positions · Total reported value $1.49B · Top-10 concentration 44.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.8% · 24 new · 28 cut · 39 exited

Active Share (vs S&P 500): 96.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.9% · vs SPY -7.0% · Prev Value $1.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.3% · vs SPY +0.2% · Latest Value $978.49M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, PFM Health Sciences, LP disclosed 60 equity positions with a combined reported value of $1.49B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were LLY ($174.08M), MRK ($65.00M), ABBV ($63.07M). By sector, the heaviest allocations are Health Care 85.3%, Industrials 5.1%. Versus the prior quarter, allocation shifted toward Health Care (+1.8pp), Industrials (+1.3pp) and away from Other (-3.5pp).

Versus the prior quarter, PFM Health Sciences, LP opened 24 new positions, trimmed 28 and fully exited 39, a turnover rate of 75.8% of positions. The portfolio's overlap with the prior quarter was 71% of names.

The largest new positions opened in Q4 2023 were VRTX ($60.57M), AVTR ($15.45M), BSX ($13.77M).

Of the 39 positions fully exited versus the prior quarter, the largest were SGEN ($59.75M), CAH ($55.55M), BIIB ($47.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • VRTX VERTEX PHARMACEUTICALS INC · $60.57M
  • AVTR AVANTOR INC · $15.45M
  • BSX BOSTON SCIENTIFIC CORP · $13.77M
  • ZBH ZIMMER BIOMET HOLDINGS INC · $13.71M
  • OM OUTSET MED INC · $5.41M
  • EYPT EYEPOINT INC · $3.95M
  • CLDX CELLDEX THERAPEUTICS INC NEW · $1.39M

Fully Exited (vs previous quarter)

  • SGEN SEAGEN INC · prev qtr: $59.75M
  • CAH CARDINAL HEALTH INC · prev qtr: $55.55M
  • BIIB BIOGEN INC · prev qtr: $47.97M
  • IRTC IRHYTHM HOLDINGS INC · prev qtr: $45.76M · history
  • ALKS ALKERMES PLC · prev qtr: $32.55M
  • SRPT SAREPTA THERAPEUTICS INC · prev qtr: $30.42M
  • DXCM DEXCOM INC · prev qtr: $29.74M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $25.90M

Insider Transactions (Form 4)

Latest PFM Health Sciences, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PFM Health Sciences, LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 96 US equity positions with a combined value of $1.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-69012 (status: Approved), registered 2008-04-10
  • Regulatory AUM (Form ADV): $1.27B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds
  • Website: pfmhealthsciences.com

Portfolio Structure

  • 96 positions · $1.14B reported value (Q2 2026)
  • Top 10 holdings = 34.6% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 5.4%
  • Average position size: $11.89M

Sector Tilt

  • Health Care 92.9%
  • Industrials 5.1%
  • Consumer Staples 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 32 new, 24 added, 40 reduced, 14 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 85.3%
Technology 1.5%
Materials 0.6%
Other 7.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 298.64K $174.08M 11.66%
11.66%
Hold
2 596.26K $65.00M 4.35%
4.35%
Hold
3 407.01K $63.07M 4.22%
4.22%
Reduce
4 148.85K $60.57M 4.06%
4.06%
New
5 125.34K $57.38M 3.84%
3.84%
Reduce
6 740.26K $56.44M 3.78%
3.78%
Add
7 200.04K $48.78M 3.27%
3.27%
Add
8 97.50K $45.14M 3.02%
3.02%
Hold
9 589.41K $44.54M 2.98%
2.98%
Add
10 557.75K $41.39M 2.77%
2.77%
Reduce
11 130.29K $41.24M 2.76%
2.76%
Reduce
12 679.08K $40.86M 2.74%
2.74%
Hold
13 155.79K $39.19M 2.62%
2.62%
Reduce
14 467.43K $37.20M 2.49%
2.49%
Reduce
15 6.48M $37.13M 2.49%
2.49%
Reduce
16 124.84K $33.79M 2.26%
2.26%
Add
17 86.83K $33.03M 2.21%
2.21%
Reduce
18 202.29K $30.84M 2.06%
2.06%
Add
19 125.52K $29.04M 1.95%
1.95%
Reduce
20 101.81K $28.82M 1.93%
1.93%
Reduce
21 51.33K $27.24M 1.82%
1.82%
Reduce
22 111.85K $25.88M 1.73%
1.73%
Reduce
23 70.09K $25.32M 1.70%
1.70%
Reduce
24 307.94K $23.95M 1.60%
1.60%
Reduce
25 118.91K $22.89M 1.53%
1.53%
Hold
26 47.68K $22.48M 1.51%
1.51%
Add
27 3.26M $21.53M 1.44%
1.44%
Reduce
28 537.96K $20.44M 1.37%
1.37%
Add
29 472.54K $19.91M 1.33%
1.33%
Hold
30 1.30M $19.03M 1.27%
1.27%
Reduce
31 335.20K $18.60M 1.25%
1.25%
Add
32 58.63K $17.56M 1.18%
1.18%
Add
33 676.74K $15.45M 1.03%
1.03%
New
34 15.00M $14.82M 0.99%
0.99%
Hold
35 656.55K $14.63M 0.98%
0.98%
Reduce
36 8.00M $14.09M 0.94%
0.94%
Reduce
37 238.14K $13.77M 0.92%
0.92%
New
38 112.66K $13.71M 0.92%
0.92%
New
39 1.22M $13.64M 0.91%
0.91%
Hold
40 3.47M $13.39M 0.90%
0.90%
Add
41 595.52K $12.87M 0.86%
0.86%
Reduce
42 19.36K $10.19M 0.68%
0.68%
Reduce
43 192.86K $8.88M 0.59%
0.59%
Add
44 10.42M $8.27M 0.55%
0.55%
Hold
45 24.31K $8.20M 0.55%
0.55%
Reduce
46 1.88M $7.68M 0.52%
0.52%
Add
47 189.74K $6.90M 0.46%
0.46%
Reduce
48 2.58M $5.49M 0.37%
0.37%
Reduce
49 999.26K $5.41M 0.36%
0.36%
New
50 1.47M $4.57M 0.31%
0.31%
Add

FAQ

What did PFM Health Sciences, LP buy in 2023-Q4?

In its 2023-Q4 13F filing, PFM Health Sciences, LP reported 60 equity positions worth $1.49B in aggregate; its largest disclosed positions were LLY ($174.08M), MRK ($65.00M), ABBV ($63.07M).

How large is PFM Health Sciences, LP's portfolio?

PFM Health Sciences, LP reported $1.49B of long equity holdings across 60 positions as of 2023-Q4. Top-10 holdings account for 44.0% of reported value.

What is PFM Health Sciences, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pfm-health-sciences/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →